Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Osteonecrosis of the jaw Stories

2012-07-16 23:02:52

Parker Waichman LLP has filed a lawsuit on behalf of an Indiana woman who suffered a left and right femur fracture after taking Fosamax, an oral bisphosphonate. According to the FDA, bisphosphonates may not provide any long-term benefits while simultaneously increasing the risk of atypical femur fractures. New York, New York (PRWEB) July 16, 2012 Parker Waichman LLP has filed a lawsuit on behalf of an Indiana woman who suffered a left and right femur fracture after taking Fosamax, an oral...

2012-07-14 23:03:30

Parker Waichman LLP has filed a lawsuit on behalf of a woman who suffered a left atypical femur fracture, allegedly due to using Fosamax (alendronate). Fosamax is part of a class of drugs known as bisphosphonates, which studies have linked to large bone fractures. New York, NY (PRWEB) July 13, 2012 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit alleging that Fosamax caused a left femur fracture and other...

2012-06-12 23:01:41

A study published online in May 2012, by the Archives of Internal Medicine, a publication of the American Medical Association, revealed that atypical femoral fractures were associated with bisphosphonate (including Fosamax) use. Fosamax, manufactured by Merck, belongs to the class of drugs known as bisphosphonates. It was approved by the FDA in 1995 and developed to treat post-menopausal osteoporosis and Paget's disease of bone. On March 3rd, 2010, the U.S FDA issued a drug safety...

2012-06-08 23:01:28

Bernstein Liebhard LLP reports that the latest Fosamax ONJ state court trial has been put on hold and instead the Court plans on trying the first group of Fosamax femur fracture lawsuits against Merck. New York, NY (PRWEB) June 08, 2012 Bernstein Liebhard LLP, a nationwide law firm representing clients who have filed Fosamax femur fracture lawsuits, reports that this group of lawsuits against Merck, the manufacturer of the widely prescribed osteoporotic drug, is moving towards trial. On...

2012-06-01 23:02:13

Bernstein Liebhard LLP reports on a new discovery order issued in the federal Merck Fosamax litigation, establishing protocols for the production of documents related to Fosamax femur fractures. New York, New York (PRWEB) June 01, 2012 Bernstein Liebhard LLP, a nationwide law firm representing clients who sustained Fosamax femur fractures as a result of taking the widely prescribed osteoporotic drug, reports that a new Case Management Order was recently issued in In re: Fosamax (Alendronate...

2012-05-27 23:02:07

Ennis & Ennis, PA Summarizes the Latest Fosamax Study that Confirms Long-Term Use of Biphosphonates, such as Fosamax and Boniva, Causes Atypical Femur Fractures (PRWEB) May 26, 2012 After the New England Journal of Medicine published their findings that use of biphosphonates is not deemed beneficial outside of a 3 to 5 year window, the Archives of Internal Medicine have confirmed that prolonged use of the drug increases risk for atypical fractures of the femur. Commonly used brand names...

2012-05-21 23:02:11

Bernstein Liebhard LLP reports on a study, which found that the FDA approved more new drugs quicker than health regulatory agencies in Europe and Canada. New York, New York (PRWEB) May 21, 2012 Bernstein Liebhard LLP, a nationwide law firm representing clients who experienced complications from dangerous drugs such as Fosamax, reports on a May 16, 2012 study published in The New England Journal of Medicine (“NEJM”) that found that the U.S. Food and Drug Administration...

2012-05-17 05:15:41

(Ivanhoe Newswire) -- New research shows when it comes to bone-cancer-related fractures, pain can be reduced by drug treatment, but no one drug is superior. Researchers undertook a systematic review of the current evidence on bisphosphonate drugs, which are used to prevent bone damage in multiple myeloma. Severe back pain is a common symptom of multiple myeloma–a type of cancer that can cause fractures in long bones and the spine. Bisphosphonate drugs may help to reduce the...

2012-05-16 11:07:11

Bone cancer-related fractures and pain can be reduced by drug treatment, but no one drug is superior, according to a review published in The Cochrane Library. Researchers undertook a systematic review of the current evidence on bisphosphonate drugs, which are used to prevent bone damage in multiple myeloma. Multiple myeloma is a type of cancer that grows in and on bones, and can cause fractures in long bones and the spine. Severe back pain is a common symptom. Bisphosphonate drugs may help...

2012-05-12 23:00:26

Ennis & Ennis P.A. Announces Free Nationwide Consultations to Patients Who Have Suffered Fosamax Femur Fractures or Osteonecrosis of the Jaw as FDA Confirms Long-Term Use of Fosamax Weakens Bones (PRWEB) May 12, 2012 According to an FDA review of biphosphonates published on May 9, 2012 in the New England Journal of Medicine, long term use of these drugs, commonly known as Boniva or Fosamax, could lead to weakened bones. In these cases, women suffered Fosamax side effects including...